{"id":51328,"date":"2022-11-29T12:02:51","date_gmt":"2022-11-29T11:02:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"modified":"2022-11-29T12:02:51","modified_gmt":"2022-11-29T11:02:51","slug":"global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","title":{"rendered":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644792\/global-small-cell-lung-cancer-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sdnp4l&amp;utm_campaign=1781596+-+Global+Small+Cell+Lung+Cancer+Clinical+Trial+Pipeline+Highlights+-+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report Small Cell Lung Cancer Pipeline Highlights &#8211; 2022, provides the most up-to-date information on key pipeline products within the global Small Cell Lung Cancer market. It covers emerging therapies for Small Cell Lung Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.\n<\/p>\n<p>\n<strong>Clinical Trial Stages:<\/strong>\n<\/p>\n<p>\nThe report provides Small Cell Lung Cancer pipeline products by clinical trial stages including both early and late stage development &#8211; phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.\n<\/p>\n<p>\n<strong>Drug Mechanism Classes:<\/strong>\n<\/p>\n<p>\nThe report provides Small Cell Lung Cancer pipeline products by their dominant mechanism of action\/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.\n<\/p>\n<p>\n<strong>Company:<\/strong>\n<\/p>\n<p>\nThe report provides Small Cell Lung Cancer pipeline products by the company.\n<\/p>\n<p>\n<strong>Short-term Launch Highlights:<\/strong>\n<\/p>\n<p>\nFind out which Small Cell Lung Cancer pipeline products will be launched in the US and Ex-US till 2025.\n<\/p>\n<p>\n<strong>SUMMARY:<\/strong>\n<\/p>\n<ul>\n<li>\nSmall Cell Lung Cancer phase 3 clinical trial pipeline products\n<\/li>\n<li>\nSmall Cell Lung Cancer phase 2 clinical trial pipeline products\n<\/li>\n<li>\nSmall Cell Lung Cancer phase 1 clinical trial pipeline products\n<\/li>\n<li>\nSmall Cell Lung Cancer preclinical research pipeline products\n<\/li>\n<li>\nSmall Cell Lung Cancer discovery stage pipeline products\n<\/li>\n<li>\nSmall Cell Lung Cancer pipeline products short-term launch highlights\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n1. Small Cell Lung Cancer Pipeline by Stages\n<\/p>\n<p>\n2. Small Cell Lung Cancer Phase 3 Clinical Trial Insights\n<\/p>\n<p>\n3. Small Cell Lung Cancer Phase 2 Clinical Trial Insights\n<\/p>\n<p>\n4. Small Cell Lung Cancer Phase 1 Clinical Trial Insights\n<\/p>\n<p>\n5. Small Cell Lung Cancer Preclinical Research Insights\n<\/p>\n<p>\n6. Small Cell Lung Cancer Discovery Stage Insights\n<\/p>\n<p>\n7. Appendix\n<\/p>\n<p>\n8. Research Methodology\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5644792\/global-small-cell-lung-cancer-clinical-trial?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sdnp4l&amp;utm_campaign=1781596+-+Global+Small+Cell+Lung+Cancer+Clinical+Trial+Pipeline+Highlights+-+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/5von1t<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;p&#114;&#x65;s&#115;&#x40;&#x72;e&#115;&#x65;a&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#97;&#x72;&#x6b;e&#116;&#x73;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report Small Cell Lung Cancer Pipeline Highlights &#8211; 2022, provides the most up-to-date information on key pipeline products within the global Small Cell Lung Cancer market. It covers emerging therapies for Small Cell Lung &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51328","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report Small Cell Lung Cancer Pipeline Highlights &#8211; 2022, provides the most up-to-date information on key pipeline products within the global Small Cell Lung Cancer market. It covers emerging therapies for Small Cell Lung ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-29T11:02:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-29T11:02:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221129005607\\\/en\\\/1649392\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\",\"name\":\"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221129005607\\\/en\\\/1649392\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-29T11:02:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221129005607\\\/en\\\/1649392\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221129005607\\\/en\\\/1649392\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report Small Cell Lung Cancer Pipeline Highlights &#8211; 2022, provides the most up-to-date information on key pipeline products within the global Small Cell Lung Cancer market. It covers emerging therapies for Small Cell Lung ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-29T11:02:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-11-29T11:02:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"},"wordCount":377,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/","name":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights - 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg","datePublished":"2022-11-29T11:02:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221129005607\/en\/1649392\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-small-cell-lung-cancer-clinical-trial-pipeline-highlights-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Small Cell Lung Cancer Clinical Trial Pipeline Highlights &#8211; 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51328"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51328\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}